See PerkinElmer in Booth #5037 at Photonics West, January 28-30, San Jose, CA

Fremont, CA -- January 28, 2003 -- PerkinElmer Optoelectronics, a global technology leader providing market-driven integrated solutions for Biomedical and Industrial segments, will highlight a range of new and enhanced technologies this week at Photonics West 2003 in San Jose, CA. From the world's most sensitive photon detector to the first fully integrated thermopile module sensor, PerkinElmer continues to provide innovative solutions for instrument OEMs and designers looking to create competitive advantage through best-in-class engineering and manufacturing practices.

PerkinElmer will demonstrate these technologies - which are available now - in booth #5037:

• SPCM-AQ4C Photon Detector - the latest addition to PerkinElmer's line of biomedical imaging technologies, which includes Channel Photomultipliers (CPMs) and Charged Coupled Devices (CCDs), the AQ4C Single Photon Counting Module (SPCM) is the industry's only four-channel photon counting card capable of detecting single photons over a wavelength range of 400nm to 1100nm. The four-channel array enables researchers to test four wavelengths (or colors) at a time, not just one, saving time and improving accuracy in drug discovery and genomic research. A breakthrough device for OEMs, the SPCM-AQ4C dovetails four SPCMs onto a single card, providing four times the throughput with half the footprint and reduced power consumption - at no additional cost to manufacturers. Available now, the AQ4C can be used for a range of applications that require examination of minute samples, including single molecule detection, high-throughput DNA sequencing, laser radars (LIDAR), adaptive optics and ultra-sensitive fluorescence detection.
• Thermopile Module Sensor (TPMI) - designed for remote temperature measurements in industrial, consumer, home appliance and automotive solutions (such as microwave ovens, ear thermometers and smoke detectors), PerkinElmer's TPMI is the industry's first thermopile detector to be fully integrated with a signal processing chip in a compact TO-5 type housing, delivering an analog output signal that is already compensated for ambient temperature changes. It contains a powerful application-specific integrated circuit (ASIC), which allows for operation without the need for additional external electronic components. TPMI also provides other state-of-the-art features, such as an adjustable low-noise amplifier, programmable memory cells, bi-directional serial digital interface and a processing unit that provides ambient temperature compensation. The TPMI sensor integrates seamlessly into OEM instrumentation and is ideal for high-volume applications that require miniaturization and simple circuitry.

The following enhanced technologies are also available for demonstration in PerkinElmer's booth:

• L-series CMOS Linear Photodiode Array - the ideal sensor for scientific applications such as visible spectroscopy and colorimetry, the L-series CMOS Linear Photodiode Array combines high quantum efficiency and a single power supply operation.
• YD5000 Series Color Line Scan Camera - designed to meet the increasing demands of advanced color imaging applications, including machine vision, document scanning, and food, pharmaceutical and printing inspection, the YD5000 Series Color Line Scan Camera features a photodiode array detection, a high-speed charge coupled scanning and digital color line scanning technology. Samples are available now for interested OEM manufacturers.
• FD2114 Cooled CCD Camera - excelling in such applications as protein quantification, fluorescent microscopy, and luminescence, the FD2114 is a cooled CCD camera with a pixel resolution of 2184 x 1472 and a 16-bit dynamic range that allows users to detect the faintest of signals in their imaging field.
• UV/VIS and NIR Spectrometers - see the real-time generation of spectra by these two high-performance spectrometer engines that operate in the UV/VIS and near infrared (NIR) wavelength ranges. PerkinElmer customizes these engines to provide integrated spectrometer solutions for biomedical OEM applications in molecular spectroscopy, clinical diagnostics and fluorimetry.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) fluctuations in the global economic and political environments; (4) markets into which we sell our products decline or do not grow as anticipated; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) our ability to produce an adequate quantity of products to meet our customers' demands; (12) the manufacture and sale of products may expose us to product liability claims; (13) our failure to maintain compliance with applicable government regulations; (14) regulatory changes; (15) our failure to comply with health care industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; and (21) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

		For Further Information:
		Media Contact: Kristen Kmetetz Porter Novelli Life Sciences 617.897.8272 (office) Kristen.kmetetz@porternovelli.com or Francine S. Bernitz Marketing Director, Illumination and Detection Solutions PerkinElmer, Inc. Francine.bernitz@perkinelmer.com 978.224.4321 (office) 781.789.3178 (cell)